相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Network Analysis of Associations Between Serum Interferon-α Activity, Autoantibodies, and Clinical Features in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2011)
Treatment for Lupus, First in 50 Years, Offers Modest Benefits, Hope to Patients
Mike Mitka
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Increased Expression of B Cell Activation Factor Supports the Abnormal Expansion of Transitional B Cells in Systemic Lupus Erythematosus
Carolina Landolt-Marticorena et al.
JOURNAL OF RHEUMATOLOGY (2011)
Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
Sandra V. Navarra et al.
LANCET (2011)
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity
Diane L. Kamen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
The Impact of Vitamin D on Dendritic Cell Function in Patients with Systemic Lupus Erythematosus
Ilan Ben-Zvi et al.
PLOS ONE (2010)
Pathogenesis of human systemic lupus erythematosus: recent advances
Jose C. Crispin et al.
TRENDS IN MOLECULAR MEDICINE (2010)
B Lymphocyte Stimulator Expression in Pediatric Systemic Lupus Erythematosus and Juvenile Idiopathic Arthritis Patients
Sandy D. Hong et al.
ARTHRITIS AND RHEUMATISM (2009)
The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus
Michael P. Cancro et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Antibody quantity versus quality after influenza vaccination
JingQi Feng et al.
VACCINE (2009)
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2008)
Vitamin D in systemic lupus erythematosus
Diane Kamen et al.
CURRENT OPINION IN RHEUMATOLOGY (2008)
BLyS inhibition eliminates primary B cells but leaves natural and acquired humoral immunity intact
Jean L. Scholz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Augmented interferon-α pathway activation in patients with Sjogren's syndrome treated with etanercept
Clio P. Mavragani et al.
ARTHRITIS AND RHEUMATISM (2007)
Disease activity assessment in SLE: do we have the right instruments?
Michelle Petri
ANNALS OF THE RHEUMATIC DISEASES (2007)
High serum IFN-α activity is a heritable risk factor for systemic lupus erythematosus
T. B. Niewold et al.
GENES AND IMMUNITY (2007)
Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms
Latisha D. Heinlen et al.
ARTHRITIS AND RHEUMATISM (2007)
The role of BLyS/BLyS receptors in anti-chromatin B cell regulation
Brian D. Hondowicz et al.
INTERNATIONAL IMMUNOLOGY (2007)
Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients
S. Malik et al.
LUPUS (2007)
Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus
Shaoqing Ju et al.
CLINICAL BIOCHEMISTRY (2006)
Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies
Jing Hua et al.
ARTHRITIS AND RHEUMATISM (2006)
Vitamin D deficiency in systemic lupus erythematosus
DL Kamen et al.
AUTOIMMUNITY REVIEWS (2006)
B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time
A. Becker-Merok et al.
LUPUS (2006)
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
CE Collins et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Combined oral contraceptives in women with systemic lupus erythematosus
M Petri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Enhanced apoptotic cell clearance capacity and B cell survival factor production by IL-10-activated macrophages: Implications for Burkitt's lymphoma
CA Ogden et al.
JOURNAL OF IMMUNOLOGY (2005)
Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome
F Lavie et al.
JOURNAL OF PATHOLOGY (2004)
G-CSF-stimulated neutrophils are a prominent source of functional BLyS
P Scapini et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome
X Mariette et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus - Longitudinal observations
W Stohl et al.
ARTHRITIS AND RHEUMATISM (2003)
Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus
MR Arbuckle et al.
LUPUS (2003)
DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
MB Litinskiy et al.
NATURE IMMUNOLOGY (2002)
Anti-Sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens
MT McClain et al.
JOURNAL OF IMMUNOLOGY (2002)
Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency
MH Yan et al.
CURRENT BIOLOGY (2001)
An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway
B Schiemann et al.
SCIENCE (2001)
Cutting edge: A role for B lymphocyte stimulator in systemic lupus erythematosus
J Zhang et al.
JOURNAL OF IMMUNOLOGY (2001)
Synthesis and release of B-lymphocyte stimulator from myeloid cells
B Nardelli et al.
BLOOD (2001)
BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population
JS Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice
SD Khare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
